RMD vs. DXCM
Compare and contrast key facts about ResMed Inc. (RMD) and DexCom, Inc. (DXCM).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RMD or DXCM.
Correlation
The correlation between RMD and DXCM is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
RMD vs. DXCM - Performance Comparison
Key characteristics
RMD:
1.01
DXCM:
-0.57
RMD:
1.69
DXCM:
-0.41
RMD:
1.24
DXCM:
0.92
RMD:
0.87
DXCM:
-0.52
RMD:
6.82
DXCM:
-0.97
RMD:
5.52%
DXCM:
32.43%
RMD:
37.39%
DXCM:
54.91%
RMD:
-61.60%
DXCM:
-94.61%
RMD:
-17.91%
DXCM:
-50.84%
Fundamentals
RMD:
$35.62B
DXCM:
$30.39B
RMD:
$7.55
DXCM:
$1.65
RMD:
32.14
DXCM:
47.15
RMD:
1.84
DXCM:
1.19
RMD:
$4.81B
DXCM:
$3.95B
RMD:
$2.75B
DXCM:
$2.44B
RMD:
$1.69B
DXCM:
$975.30M
Returns By Period
In the year-to-date period, RMD achieves a 39.22% return, which is significantly higher than DXCM's -35.50% return. Over the past 10 years, RMD has underperformed DXCM with an annualized return of 16.86%, while DXCM has yielded a comparatively higher 19.53% annualized return.
RMD
39.22%
-1.77%
15.80%
37.00%
9.70%
16.86%
DXCM
-35.50%
6.38%
-31.38%
-34.82%
8.46%
19.53%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
RMD vs. DXCM - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for ResMed Inc. (RMD) and DexCom, Inc. (DXCM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RMD vs. DXCM - Dividend Comparison
RMD's dividend yield for the trailing twelve months is around 0.85%, while DXCM has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RMD ResMed Inc. | 0.85% | 1.07% | 0.83% | 0.62% | 0.73% | 0.98% | 1.26% | 1.61% | 2.03% | 2.16% | 1.89% | 1.78% |
DXCM DexCom, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RMD vs. DXCM - Drawdown Comparison
The maximum RMD drawdown since its inception was -61.60%, smaller than the maximum DXCM drawdown of -94.61%. Use the drawdown chart below to compare losses from any high point for RMD and DXCM. For additional features, visit the drawdowns tool.
Volatility
RMD vs. DXCM - Volatility Comparison
The current volatility for ResMed Inc. (RMD) is 7.89%, while DexCom, Inc. (DXCM) has a volatility of 11.34%. This indicates that RMD experiences smaller price fluctuations and is considered to be less risky than DXCM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RMD vs. DXCM - Financials Comparison
This section allows you to compare key financial metrics between ResMed Inc. and DexCom, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities